Ignite Creation Date:
2024-05-06 @ 1:30 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04042558
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2019-07-29
Brief Title:
A Study Evaluating Platinum-Pemetrexed-Atezolizumab -Bevacizumab for Patients With Stage IIIBIV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
Sponsor:
Centre Francois Baclesse
Organization:
Centre Francois Baclesse
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-29
First Submit QC Date:
August 1 2019
Study First Post Date:
2019-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-07
Last Update Post Date:
2023-08-01
Last Update Post Date Type:
ACTUAL